Pubdate: Fri, 09 Jul 2010 Source: Times Union (Albany, NY) Copyright: 2010 Capital Newspapers Division of The Hearst Corporation Contact: http://www.timesunion.com/forms/emaileditor.asp Website: http://www.timesunion.com/ Details: http://www.mapinc.org/media/452 Referenced: http://www.mapinc.org/drugnews/v10/n507/a04.html Author: Paul Armentano POT OFFERS SAFE, MEDICAL RELIEF Critics' claim that marijuana is "too dangerous" a substance to allow for therapeutic purposes demonstrates a willful ignorance of the science surrounding its use ("Medical marijuana too dangerous, costly," June 30). For example, in February, the results of a series of randomized, placebo-controlled clinical trials performed by the University of California concluded that inhaled cannabis is safe and effective as a medicine, particularly in the treatment of multiple sclerosis and neuropathic pain. Months earlier, the American Medical Association's Council on Science and Public Health reported, "Results of short term controlled trials indicate that smoked cannabis reduces neuropathic pain, improves appetite and caloric intake especially in patients with reduced muscle mass, and may relieve spasticity and pain in patients with multiple sclerosis." Cannabinoids, the therapeutic components in the marijuana plant, are virtually non-toxic to healthy cells and organs, do not depress the central nervous system and are incapable of causing a fatal overdose. By contrast, most readily available prescription and over the counter drugs, including acetaminophen and ibuprofen, possess a variety of toxic side effects -- including liver failure and death. Objective science, not rhetoric, should guide New York's marijuana policies. It makes no sense to continue to arrest and prosecute people who find therapeutic relief from cannabis. Paul Armentano Washington, D.C. norml.org The writer is deputy director of NORML, the National Organization for the Reform of Marijuana Laws, and co-author of "Marijuana Is Safer: So Why Are We Driving People to Drink?" - --- MAP posted-by: Matt